OMOSEFE CHRISTINA LIMITEDActive

Company number 13123249Private limited companyIncorporated 2021

Key figures

£170-95.5%
Net assets 2025/26
-58.3%
Average annual change 2021/22–2025/26
02 k4 k6 k8 k2021/222022/232023/242024/252025/26

Like most small UK companies, OMOSEFE CHRISTINA LIMITED does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Ratios

2025/26
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
010 k20 k2021/222022/232023/242024/252025/26
Filed accounts2021/22–2025/26
2021/222022/232023/242024/252025/26
Total assets1,7341,1975454,2852,600
Total liabilities7,3718,0608,2724902,430
Net assets / total equity5,6376,8637,7273,795170
Average number of employees00000

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Summary: OMOSEFE CHRISTINA LIMITED

Company

OMOSEFE CHRISTINA LIMITED is a private limited company registered with Companies House under company number 13123249. It was incorporated on 8 Jan 2021. Its status is active. The registered office is in Stockton-on-tees (TS17). Its nature of business (SIC 2007) is retail sale of medical and orthopaedic goods in specialised stores (not incl. hearing aids) n.e.c. (47749), other business support service activities n.e.c. (82990), medical nursing home activities (86102), general medical practice activities (86210).

Accounts

The latest accounts in the database are for 2025/26 (period ending 31 Jan 2026); the company files micro-entity accounts. Net assets were £170, down 95.5% on the previous year. Total assets were £2,600 and total liabilities £2,430. The company had an average of 0 employees. Figures are available for 5 financial years (2021/22–2025/26).

Control and charges

One person with significant control is registered.

Filing deadlines

The next accounts are due by 31 Oct 2027. The next confirmation statement is due by 11 Dec 2026.